Shree Govardhan Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 148.20%
- Profit Growth 67.60%
- Ebitda 68.53%
- Net Worth -62.89%
- Total Assets 92.74%
About Shree Govardhan Pharma
Shree Govardhan Pharma Private Limited (SGPPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 October 2018 (Six years and three months 28 days old ). Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ramjas Burdak, Bholashankar Prajapati, and Priya Anand serve as directors at the Company.
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U36900RJ2018PTC062825
- Company No.
062825
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Oct 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Shree Govardhan Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramjas Burdak  | Director | 25-Oct-2018 | Current |
| Bholashankar Prajapati | Director | 25-Oct-2018 | Current |
| Priya Anand | Director | 16-Sep-2019 | Current |
Financial Performance of Shree Govardhan Pharma.
Shree Govardhan Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 148.2% increase. The company also saw a substantial improvement in profitability, with a 67.6% increase in profit. The company's net worth observed a substantial decline by a decrease of 62.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shree Govardhan Pharma?
In 2019, Shree Govardhan Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Wooden Bench Holidays And Hospitality Private LimitedPriya Anand is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shree Govardhan Pharma?
Unlock and access historical data on people associated with Shree Govardhan Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shree Govardhan Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Govardhan Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.